"10.1371_journal.pone.0059773","plos one","2013-03-19T00:00:00Z","Barbara Klink; Hrvoje Miletic; Daniel Stieber; Peter C Huszthy; Jaime Alberto Campos Valenzuela; Jörg Balss; Jian Wang; Manja Schubert; Per Øystein Sakariassen; Terje Sundstrøm; Anja Torsvik; Mads Aarhus; Rupavathana Mahesparan; Andreas von Deimling; Lars Kaderali; Simone P Niclou; Evelin Schröck; Rolf Bjerkvig; Janice M Nigro","Institut für Klinische Genetik, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Department of Biomedicine, University of Bergen, Bergen, Norway; The Gade Institute, Department of Pathology, Haukeland University Hospital, Bergen, Norway; Centre de Recherche Public de la Santé, Luxembourg; Department for Histology and Embryology, School of Medicine, University of Rijeka, Rijeka, Croatia; Institut für Medizinische Informatik und Biometrie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Oncomatrix Research Laboratory, Department of Biomedicine, University of Bergen, Jonas Bergen, Norway; Department of Clinical Medicine, Section Neurology, Haukeland University Hospital, Bergen, Norway; Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway; Department of Surgical Sciences, University of Bergen, Bergen, Norway; Department of Neurosurgery, Oslo University Hospital, Oslo, Norway; Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany","Conceived and designed the experiments: JMN. Performed the experiments: JMN BK HM DS PCH JACV JB JW MS TS AT. Analyzed the data: JMN BK HM DS PCH JACV JB JW TS AT AvD SPN LK ES. Contributed reagents/materials/analysis tools: PØS MA RM. Wrote the paper: JMN RB BK.","The authors have read the journals policy and have the following conflicts: Jörg Balss and Andreas von Deimling applied for a patent on the biochemical assay for 2-hydroxyglutarate detection. All terms are being managed by the German Cancer Cover Letter Research Center in accordance with its conflict of interest policies. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. Number EP 12 157 663.1 is the number for the European patent application submitted 01 March, 2012 and entitled Means and Methods for the Determination of (D)-2-Hydroxyglutarate (D2HG).","2013","03","Barbara Klink","BK",19,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
